Category: Investors

BNDES approves $150 million loan for GranBio

In Brazil, Reuters reports that BNDES has approved a $150 million loan for GranBio Investimentos Group’s cellulosic ethanol plant.  The plant will be built in São Miguel dos Campos. Using cane bagasse, the plant is expected to produce just under 22 million gallons every growing season. Reuters reports that GranBio is working on production of [...]

May 15, 2013 More

IBK Capital engaged by Peat Resources to raise up to $100,000

In Canada, IBK Capital Corp. has been engaged by Peat Resources Limited to complete a best efforts private placement of up to $100,000. The placement consists of 2,500,000 units at $0.04 per unit. Each unit consists of one common share and one common share purchase warrant, which is exercisable for one year from the closing [...]

May 15, 2013 More

Barclays, Credit Suisse and Societe Generale provide bookrunning for BioAmber IPO

In Canada, Barclays, Credit Suisse and Societe Generale are joint bookrunners for BioAmber’s IPO. Originally slated to sell 8 million shares in the price range of $15 to $17, the current plan is to offer the share at a price range of $10 to $12, anticipating that the price will allow BioAmber to raise $88 [...]

May 8, 2013 More

CLSA Capital Partners invests $10 million in Camson Bio Technologies

In Hong Kong, DealCurry reports that CLSA Capital Partners is investing $10 million in Camson Bio Technologies. In return, Camson will issue over 41 million shares at $1.1 per share, and over 16 million convertible warrants priced at $3.21 each. The articles states that will give CLSA a 19.6% stake in Camson. Camson is a [...]

May 8, 2013 More

Friends Life extends loan facility to Drax

In the United Kingdom, Friends Life has extended a £75 million amortizing loan facility to Drax Group, underpinned by a guarantee from HM Treasury issued under the Infrastructure UK Guarantee Scheme. The loan facility replaces £50 million of the £100 million amortizing loan facility between Drax and UK Green Investment Bank, and will mature in [...]

May 1, 2013 More

Green Investment Bank and Masdar to form new investment alliance

In the United Kingdom, the UK Green Investment Bank and Masdar, Abu Dhabi’s state-backed renewable energy company, have confirmed that they will sign a Memorandum of Understanding to explore project investment opportunities in the UK’s clean energy sector. Under the MoU, the two parties will consider opportunities to jointly invest in green infrastructure projects in [...]

May 1, 2013 More

Farm Credit Canada loans $3 million to Innovente

In Canada, Farm Credit Canada has agreed to loan Innovente up to a maximum amount of $3 million. Innovente will use the loan primarily for commercial operation of the first cogeneration plant of Innovente located at Saint-Patrice-de-Beaurivage, which is set to occur in the coming weeks. “FCC is proud to support Innovente in its innovative [...]

April 24, 2013 More

H.C. Wainwright acts as placement agent for Northwest Biotherapeutics in $10 million stock transaction

In Maryland, H.C. Wainwright & Co acted as the exclusive placement agent for a transaction between Northwest Biotherapeutics and a single healthcare dedicated institutional investor for a registered direct placement of $10 million of common stock at the closing market price of $3.90 per share. Northwest will also issue to the investor warrant coverage of [...]

April 24, 2013 More

Polaris Partners leads round of $14.5 million Series A financing for AgBiome

In North Carolina, AgBiome reports that Polaris Partners lead a Series A financing round that  has secured $14.5 million in Series A financing to further advance AgBiome’s and development programs, and support the launch of the company’s first products. Polaris was by ARCH Venture Partners, Harris & Harris Group, Innotech Advisers, and additional strategic investors.

April 17, 2013 More

Bergamo Acquisitions invests $36 million VistaGen Therapeutics

In Nevada, Bergamo Acquistions’ European subsidiary has signed a strategic financing agreement with VistaGen Therapeutics.  Under the terms of the agreement, Bergamo’s European subsidiary will invest $36 million in VistaGen in consideration for 72 million shares of restricted VistaGen Common Stock at a price of $0.50 per share. The transaction is scheduled to close on or [...]

April 17, 2013 More